Inhibition of the receptor tyrosine kinase ROR1 by anti-ROR1 monoclonal antibodies and siRNA induced apoptosis of melanoma cells

被引：1
|
作者：
Farsangi, Mohammad Hojat
Ghaemimanesh, Fatemeh
Daneshmanes, Amir Hossein
Bayat, Ali-Ahmad
Mahmoudian, Jafar
Jeddi-Tehrani, Mahmood
Mellstedt, Hakan
机构：
[1] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden
[2] Karolinska Univ, Hosp Solna, Stockholm, Sweden
[3] ACECR, Avicenna Res Inst, Monoclonal Antibody Res Ctr, Tehran, Iran
[4] Karolinska Univ, Hosp Solna, CCK, Immune & Gene Therapy Lab,Canc Ctr Karolinska, Stockholm, Sweden
[5] Karolinska Inst, Stockholm, Sweden
[6] Karolinska Inst, Dept Oncol Radiumhemmet & Hematol, Stockholm, Sweden
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e22198
引用
收藏
页数：1
相关论文
共 50 条
  • [1] RETRACTED: Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma Cells (Retracted article. See vol. 17, 2022)
    Hojjat-Farsangi, Mohammad
    Ghaemimanesh, Fatemeh
    Daneshmanesh, Amir Hossein
    Bayat, Ali-Ahmad
    Mahmoudian, Jafar
    Jeddi-Tehrani, Mahmood
    Rabbani, Hodjatallah
    Mellstedt, Hakan
    [J]. PLOS ONE, 2013, 8 (04):
  • [2] RETRACTION: Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma Cells (Retraction of Vol 8, art no E61167, 2013)
    Hojjat-Farsangi, M.
    Ghaemimanesh, F.
    Daneshmanesh, A. H.
    Bayat, A-A
    Mahmoudian, J.
    Jeddi-Tehrani, M.
    [J]. PLOS ONE, 2022, 17 (05):
  • [3] ANTI-ROR1 MONOCLONAL ANTIBODIES INDUCED APOPTOSIS OF CLL CELLS AND ALTERED PHOSPHORYLATION OF SRC AND PI3-KINASES
    Daneshmanesh, A. H.
    Hojjat-Farsangi, M.
    Moshfegh, A.
    Mikaelsson, E.
    Khan, A. S.
    Osterborg, A.
    Mellstedt, H.
    [J]. HAEMATOLOGICA, 2014, 99 : 51 - 52
  • [4] Tyrosine Kinase ROR1 as a Target for Anti-Cancer Therapies
    Zhao, Yuming
    Zhang, Dengyang
    Guo, Yao
    Lu, Bo
    Zhao, Zhizhuang Joe
    Xu, Xiaojun
    Chen, Yun
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [5] Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells
    Choudhury, Aniruddha
    Derkow, Katja
    Daneshmanesh, Amir Hossein
    Mikaelsson, Eva
    Kiaii, Shahryar
    Kokhaei, Parviz
    Osterborg, Anders
    Mellstedt, Hakan
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 151 (04) : 327 - 335
  • [6] Therapeutic Potential and Challenges of Targeting Receptor Tyrosine Kinase ROR1 with Monoclonal Antibodies in B-Cell Malignancies
    Yang, Jiahui
    Baskar, Sivasubramanian
    Kwong, Ka Yin
    Kennedy, Michael G.
    Wiestner, Adrian
    Rader, Christoph
    [J]. PLOS ONE, 2011, 6 (06):
  • [7] Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development
    Al-Shawi, R
    Ashton, SV
    Underwood, C
    Simons, JP
    [J]. DEVELOPMENT GENES AND EVOLUTION, 2001, 211 (04) : 161 - 171
  • [8] Expression of the receptor tyrosine kinase genes, Ror1 and Ror2, during mouse development
    Matsuda, T
    Nomi, M
    Ikeya, M
    Kani, S
    Oishi, I
    Terashima, T
    Tawada, S
    Minami, Y
    [J]. MECHANISMS OF DEVELOPMENT, 2001, 105 (1-2) : 153 - 156
  • [9] Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development
    [J]. Development Genes and Evolution, 2001, 211 : 161 - 171
  • [10] Anti-ROR1 monoclonal antibodies induce apoptosis in pancreatic cancer cells via the PI3-kinase/AKT/mTOR pathway
    Daneshmanesh, Amir Hossein
    Hojjat-Farsangi, Mohammad
    Moshfegh, Ali
    Mikaelsson, Eva
    Khan, Abdul Salam
    Osterborg, Anders
    Mellstedt, Hakan
    [J]. CANCER RESEARCH, 2014, 74 (19)
12345